These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11924158)

  • 1. Kigris. FDA approves first biologic for sepsis.
    Nursing; 2002 Feb; 32(2):18. PubMed ID: 11924158
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing the use of activated protein C in the treatment of severe sepsis.
    Siegel JP
    N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves first biologic treatment for sepsis.
    FDA Consum; 2002; 36(1):3. PubMed ID: 11881595
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks and benefits of activated protein C treatment for severe sepsis.
    Warren HS; Suffredini AF; Eichacker PQ; Munford RS
    N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562
    [No Abstract]   [Full Text] [Related]  

  • 5. Drotrecogin alfa on trial.
    Tillotson GS
    Lancet Infect Dis; 2009 Jan; 9(1):2-3. PubMed ID: 19095188
    [No Abstract]   [Full Text] [Related]  

  • 6. Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.
    Eichacker PQ; Danner RL; Suffredini AF; Cui X; Natanson C
    Crit Care Med; 2005 Oct; 33(10):2426-8. PubMed ID: 16215410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe sepsis and therapy with activated protein C.
    Parrillo JE
    N Engl J Med; 2005 Sep; 353(13):1398-400. PubMed ID: 16192486
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves first biologic treatment for sepsis.
    Dent Today; 2002 Mar; 21(3):28, 30. PubMed ID: 11915215
    [No Abstract]   [Full Text] [Related]  

  • 10. [Xigris--activated protein C].
    Tønnesen EK
    Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235
    [No Abstract]   [Full Text] [Related]  

  • 11. Conclusions: drotrecogin alfa (activated)--from bench to practical use at the bedside.
    Maki DG
    Am J Surg; 2002 Dec; 184(6A Suppl):S47-50. PubMed ID: 12521617
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioethics, the Surviving Sepsis Campaign, and the industry.
    Wiedermann CJ
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):442-4. PubMed ID: 16091869
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioethics, the Surviving Sepsis Campaign and the industry.
    Bion J; Vincent JL; Angood P
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63. PubMed ID: 16489529
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated protein C for severe sepsis.
    Ely EW; Bernard GR; Vincent JL
    N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying patients with severe sepsis who should not be treated with drotrecogin alfa (activated).
    Morris PE; Light RB; Garber GE
    Am J Surg; 2002 Dec; 184(6A Suppl):S19-24. PubMed ID: 12521614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Röggla G; Moser B
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):65. PubMed ID: 16612881
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Ricevuti G; Gasparetto C
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64-5. PubMed ID: 16612880
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Mackenzie AF
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64. PubMed ID: 16612879
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Malliani A
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63-4. PubMed ID: 16612878
    [No Abstract]   [Full Text] [Related]  

  • 20. Activated protein C: do more survive?
    Ridley S
    Intensive Care Med; 2006 Apr; 32(4):608; author reply 610-2. PubMed ID: 16508755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.